Back to top

cancer: Archive

Debanjana Dey

Champions Oncology vs. Biodesix: Which Oncology Stock Is a Better Buy?

CSBR and BDSX ride on distinct oncology growth drivers, but which stock looks more compelling amid contrasting performance and valuations? Let's dive in.

CSBRNegative Net Change BDSXNegative Net Change

Kinjel Shah

Cancer Stocks to Consider as Oncology Innovation Accelerates

Oncology stocks are gaining relevance as cancer care evolves, with Pfizer, Merit Medical Systems and Abbott advancing treatments, diagnostics and screening technologies.

ABTNegative Net Change PFENegative Net Change MMSINegative Net Change AZNNegative Net Change NVSNegative Net Change JNJPositive Net Change ABBVPositive Net Change

Debanjana Dey

PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?

Precipio and Fulgent Genetics differ in business scope, valuation and growth drivers, but which cancer diagnostics stock looks more compelling now? Let's dive in.

FLGTNegative Net Change PRPONegative Net Change

Zacks Equity Research

Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough

Merck-Moderna's melanoma vaccine success could boost immunotherapy growth, putting healthcare ETFs in the spotlight.

MRKPositive Net Change MRNANegative Net Change XBINegative Net Change PPHNegative Net Change IDNANegative Net Change CANCNegative Net Change BMYPositive Net Change

Kinjel Shah

Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves

Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing cancer-focused therapies and technologies.

MMSINegative Net Change KURANegative Net Change IOVANegative Net Change AZNNegative Net Change NVSNegative Net Change JNJPositive Net Change PFENegative Net Change

Ekta Bagri

5 Biotech Stocks Worth Adding to Your Portfolio Now

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position HALO, RGEN, IOVA, ARQT and PGEN in this volatile sector.

HALONegative Net Change RGENNegative Net Change IOVANegative Net Change PGENPositive Net Change ARQTNegative Net Change

Debanjana Dey

PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?

Precipio and Biodesix take different approaches to cancer diagnostics, but which stock looks more compelling now? Let's dive in.

PRPONegative Net Change BDSXNegative Net Change

Shaun Pruitt

Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?

Shares of Moderna (MRNA) and Merck (MRK) are soaring Wednesday after the companies reported a potentially historic breakthrough for their personalized mRNA cancer vaccine.

MRKPositive Net Change MRNANegative Net Change

Mark Vickery

Earnings, Cancer Vaccine, Long-Term Liquidity: A Busy Pre-Market

Q2 retail earnings continue, Moderna sees positive Phase 3 results, and the Treasury lowers the longer-term bond rate.

MRKPositive Net Change TGTNegative Net Change TJXPositive Net Change LOWPositive Net Change ELNegative Net Change MRNANegative Net Change

Ekta Bagri

BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?

Bristol Myers Squibb's Growth Portfolio and pipeline support momentum, but generic headwinds and recent gains call for a cautious stance.

BMYPositive Net Change PFENegative Net Change MRKPositive Net Change